[ TRANSACTION RECORD ]

Novo Holdings A/S Investment in MorphoSys — 2024

VERIFIED VECTOR ID: 001822 · tx-108
M SOURCE NODE — FUNDER
Novo Holdings A/S
Healthcare Denmark
$2,900,000,000
EQUITY
31/05/2024
Q DESTINATION NODE — RECIPIENT
MorphoSys
Company Germany
Amount (USD)
$2.9B
Flow Type
EQUITY
Transaction Date
31/05/2024
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Novo Holdings A/S
AUM 115000
HQ Location Denmark
Sector Healthcare
Recipient Profile [ Q ]
Entity MorphoSys
Entity Type Company
Jurisdiction Germany
Intelligence Note

Novartis completed a 2.9 billion dollar tender offer for MorphoSys to strengthen its oncology pipeline with advanced treatments for blood cancers. The transaction includes pelabresib, a promising therapy for myelofibrosis. This deal reflects the continued focus of major pharmaceutical firms on acquiring established biotech companies with proven therapeutic platforms.

Σ
Primary Forensic Source https://www.novartis.com/news/media-releases/novartis-completes-tender-offer-morphosys-ag/
✓ SOURCE LINKED